| Description | BCR-ABL-IN-6 (9h) is an imatinib derivative and a selective inhibitor of Bcr-Abl kinase that acts on Bcr-AblWT (IC50: 4.6 nM) and Bcr-AblT3151 (IC50: 277 nM). BCR-ABL-IN-6 (9h) was able to be used in the study of chronic myeloid leukemia treatment. |
| molecular weight | 505.49 |
| Molecular formula | C27H22F3N5O2 |
| CAS | 2499499-26-0 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year |